MEHR VC is a healthcare investment platform, built to institutional standard, led by operator-investors with venture and private-equity experience, and backed by venture partners and senior advisors across healthcare science, venture capital, and global capital markets.
MEHR VC leads with people and process: an experienced operator-investor team, venture partners and advisors of real standing, and the conviction to back healthcare's most consequential companies.
Operator-investors who underwrite on clinical, regulatory, and commercial merit, and who've been accountable for the outcome, not just the recommendation.
A platform built to move between the United States, Europe, the Gulf, and Asia, unlocking access few platforms can reach.
Built to institutional standard from the first day: clean structure, disciplined concentration, and the caliber of people sophisticated capital expects.
MEHR VC's edge is the combination of an experienced operator-investor team and the discipline to back conviction with rigor. People and process decide what we invest in, and how.
A team that has sourced, structured, and negotiated institutional capital agreements at nine-figure scale across venture and private equity.
Institutional-grade structure, governance, and documentation from day one, the discipline sophisticated capital looks for first.
A platform designed to take high-conviction positions in the healthcare companies that matter most.
Healthcare is our home. Where a specific opportunity calls for adjacent expertise, we bring the right people in through our network, deliberately, and case by case.
MEHR VC is led by two PharmD-trained operator-investors with venture and private-equity-style experience structuring and negotiating institutional capital agreements at nine-figure scale across the United States, Europe, and the Gulf.
PharmD-trained operator-investor. Leads origination, relationships, and cross-border access across the US and Europe, the front edge of MEHR's deal engine.
PharmD-trained operator-investor. Leads diligence, structuring, and strategy, the clinical and analytical rigor behind every underwriting decision.
MEHR VC is backed by venture partners and senior advisors across healthcare science, venture capital, and global capital markets, including partners at leading venture firms, founders of public healthcare companies, and veterans of the world's leading investment banks. We will introduce them by name in due course.
We review introductions on a rolling basis and prefer to build relationships warm. For hands-on engagements, visit our partner practice.